Cresco Labs Statistics
Total Valuation
Cresco Labs has a market cap or net worth of $538.88 million. The enterprise value is $1.11 billion.
| Market Cap | 538.88M |
| Enterprise Value | 1.11B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Cresco Labs has 328.59 million shares outstanding. The number of shares has increased by 12.12% in one year.
| Shares Outstanding | 328.59M |
| Shares Change (YoY) | +12.12% |
| Shares Change (QoQ) | +0.42% |
| Owned by Insiders (%) | 0.71% |
| Owned by Institutions (%) | 7.95% |
| Float | 309.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 113.64 |
| PS Ratio | 0.70 |
| Forward PS | 0.70 |
| PB Ratio | 1.07 |
| P/FCF Ratio | 11.15 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.12, with an EV/FCF ratio of 22.88.
| EV / Earnings | n/a |
| EV / Sales | 1.45 |
| EV / EBITDA | 8.12 |
| EV / EBIT | 17.29 |
| EV / FCF | 22.88 |
Financial Position
The company has a current ratio of 1.36, with a Debt / Equity ratio of 1.38.
| Current Ratio | 1.36 |
| Quick Ratio | 0.84 |
| Debt / Equity | 1.38 |
| Debt / EBITDA | 5.08 |
| Debt / FCF | 14.32 |
| Interest Coverage | 1.13 |
Financial Efficiency
Return on equity (ROE) is -30.33% and return on invested capital (ROIC) is -5.15%.
| Return on Equity (ROE) | -30.33% |
| Return on Assets (ROA) | -11.23% |
| Return on Capital (ROIC) | -5.15% |
| Revenue Per Employee | $277,303 |
| Profits Per Employee | -$55,259 |
| Employee Count | 2,760 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 3.52 |
Taxes
In the past 12 months, Cresco Labs has paid $34.28 million in taxes.
| Income Tax | 34.28M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.65% in the last 52 weeks. The beta is 1.98, so Cresco Labs's price volatility has been higher than the market average.
| Beta (5Y) | 1.98 |
| 52-Week Price Change | -4.65% |
| 50-Day Moving Average | 1.79 |
| 200-Day Moving Average | 1.80 |
| Relative Strength Index (RSI) | 45.92 |
| Average Volume (20 Days) | 521,797 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cresco Labs had revenue of $765.36 million and -$152.51 million in losses. Loss per share was -$0.47.
| Revenue | 765.36M |
| Gross Profit | 355.29M |
| Operating Income | -61.60M |
| Pretax Income | -119.67M |
| Net Income | -152.51M |
| EBITDA | 136.27M |
| EBIT | 64.00M |
| Loss Per Share | -$0.47 |
Balance Sheet
The company has $124.77 million in cash and $692.31 million in debt, giving a net cash position of -$567.54 million or -$1.73 per share.
| Cash & Cash Equivalents | 124.77M |
| Total Debt | 692.31M |
| Net Cash | -567.54M |
| Net Cash Per Share | -$1.73 |
| Equity (Book Value) | 502.79M |
| Book Value Per Share | 1.53 |
| Working Capital | 75.85M |
Cash Flow
In the last 12 months, operating cash flow was $91.67 million and capital expenditures -$43.32 million, giving a free cash flow of $48.35 million.
| Operating Cash Flow | 91.67M |
| Capital Expenditures | -43.32M |
| Free Cash Flow | 48.35M |
| FCF Per Share | $0.14 |
Margins
Gross margin is 46.42%, with operating and profit margins of -8.05% and -19.93%.
| Gross Margin | 46.42% |
| Operating Margin | -8.05% |
| Pretax Margin | -15.64% |
| Profit Margin | -19.93% |
| EBITDA Margin | 17.80% |
| EBIT Margin | 8.36% |
| FCF Margin | 6.32% |
Dividends & Yields
Cresco Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.12% |
| Shareholder Yield | -12.12% |
| Earnings Yield | -28.30% |
| FCF Yield | 8.97% |
Analyst Forecast
The average price target for Cresco Labs is $2.50, which is 52.44% higher than the current price. The consensus rating is "Buy".
| Price Target | $2.50 |
| Price Target Difference | 52.44% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 3, 2018. It was a reverse split with a ratio of 1:812.
| Last Split Date | Dec 3, 2018 |
| Split Type | Reverse |
| Split Ratio | 1:812 |
Scores
Cresco Labs has an Altman Z-Score of -0.18 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.18 |
| Piotroski F-Score | 5 |